Clinical Trials Directory

Trials / Unknown

UnknownNCT01043679

Efficacy and Safety of Utapine vs. Seroquel in Patients With Bipolar Mania

A Randomized Open-label Active-controlled Study to Evaluate the Efficacy and Safety of Utapine Versus Seroquel in Patients With Bipolar Mania

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Taichung Veterans General Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The goal of this research is to evaluate the safety as well as effectiveness of Utapine and Seroquel in bipolar I disorder patients.

Detailed description

Utapine and Serquel belong to anti-bipolar medication family, both are approved by DOH (Department of Health, Taiwan), both has same ingredient but different manufacture. From clinical trial reports, both has excellent effectiveness and safety. The goal of this research is to evaluate the safety as well as effectiveness of Utapine and Seroquel in bipolar I disorder patients for different ingredient and different manufacture.

Conditions

Interventions

TypeNameDescription
DRUGUtapineEfficacy and Safety of Utapine
DRUGSeroquelEfficacy and Safety of Seroquel

Timeline

Start date
2009-07-01
Primary completion
2010-06-01
Completion
2010-06-01
First posted
2010-01-07
Last updated
2010-01-15

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01043679. Inclusion in this directory is not an endorsement.